Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy
In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is a...
Gespeichert in:
Veröffentlicht in: | Clinical nuclear medicine 1994-01, Vol.19 (1), p.64-65 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 65 |
---|---|
container_issue | 1 |
container_start_page | 64 |
container_title | Clinical nuclear medicine |
container_volume | 19 |
creator | RETTENBACHER, LUKAS GALVAN, GÜNTHER |
description | In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging. |
doi_str_mv | 10.1097/00003072-199401000-00018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76406463</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76406463</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2808-7ac7d7bcd8391419500f278c722d14dd53e86debceab701f8e562ff1a911153b3</originalsourceid><addsrcrecordid>eNp1kc-O1DAMxiMEWoaFR0DKAXErJE0naY8w_BmkASR2EcfKTdxp2DTtJqlGfQZeiSfgqchqR9ywZNmWf_osfSaEcvaKs0a9ZjkEU2XBm6ZiPE9FTl4_IBu-FbJgZdk8JBsmpCgaJcvH5EmMPzMhuawuyEXNhdo2bEN-vbN9jwF9spDs5OlbTCdET79htGYBR3fgNQYK3tDrYR2tpvt1xjA7iBao9fQzOHv04BP9MvliP5njjfV_fkd6WMd5mEagP2wa6FXu0hRTPnOnrnFOU6BX2ubTxwDzsD4lj3pwEZ-d6yX5_uH99W5fHL5-_LR7cyjmsmZ1oUArozptatHwijdbxvpS1VqVpeGVMVuBtTTYaYROMd7XuJVl33NoOM_mdOKSvLzXncN0u2BM7WijRufA47TEVsmKyUqKDD4_g0s3omnnYEcIa3t2L-9fnPcQNbg-ZKts_IdVjEnB7mSqe-w0uYQh3rjlhKEdEFwa2v-9UvwFjOaSeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76406463</pqid></control><display><type>article</type><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</creator><creatorcontrib>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</creatorcontrib><description>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/00003072-199401000-00018</identifier><identifier>PMID: 8137590</identifier><identifier>CODEN: CNMEDK</identifier><language>eng</language><publisher>Philadelphia, PA: Lippincott-Raven Publishers</publisher><subject>Biological and medical sciences ; Child, Preschool ; Citrates ; Citric Acid ; Diagnosis, Differential ; Gallium Radioisotopes ; Hematologic and hematopoietic diseases ; Humans ; Indium Radioisotopes ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Lymphoma, Non-Hodgkin - diagnostic imaging ; Medical sciences ; Octreotide ; Radionuclide Imaging ; Receptors, Somatostatin ; Thymus Hyperplasia - diagnostic imaging</subject><ispartof>Clinical nuclear medicine, 1994-01, Vol.19 (1), p.64-65</ispartof><rights>Lippincott-Raven Publishers.</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4006303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8137590$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>RETTENBACHER, LUKAS</creatorcontrib><creatorcontrib>GALVAN, GÜNTHER</creatorcontrib><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</description><subject>Biological and medical sciences</subject><subject>Child, Preschool</subject><subject>Citrates</subject><subject>Citric Acid</subject><subject>Diagnosis, Differential</subject><subject>Gallium Radioisotopes</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Indium Radioisotopes</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Lymphoma, Non-Hodgkin - diagnostic imaging</subject><subject>Medical sciences</subject><subject>Octreotide</subject><subject>Radionuclide Imaging</subject><subject>Receptors, Somatostatin</subject><subject>Thymus Hyperplasia - diagnostic imaging</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc-O1DAMxiMEWoaFR0DKAXErJE0naY8w_BmkASR2EcfKTdxp2DTtJqlGfQZeiSfgqchqR9ywZNmWf_osfSaEcvaKs0a9ZjkEU2XBm6ZiPE9FTl4_IBu-FbJgZdk8JBsmpCgaJcvH5EmMPzMhuawuyEXNhdo2bEN-vbN9jwF9spDs5OlbTCdET79htGYBR3fgNQYK3tDrYR2tpvt1xjA7iBao9fQzOHv04BP9MvliP5njjfV_fkd6WMd5mEagP2wa6FXu0hRTPnOnrnFOU6BX2ubTxwDzsD4lj3pwEZ-d6yX5_uH99W5fHL5-_LR7cyjmsmZ1oUArozptatHwijdbxvpS1VqVpeGVMVuBtTTYaYROMd7XuJVl33NoOM_mdOKSvLzXncN0u2BM7WijRufA47TEVsmKyUqKDD4_g0s3omnnYEcIa3t2L-9fnPcQNbg-ZKts_IdVjEnB7mSqe-w0uYQh3rjlhKEdEFwa2v-9UvwFjOaSeg</recordid><startdate>199401</startdate><enddate>199401</enddate><creator>RETTENBACHER, LUKAS</creator><creator>GALVAN, GÜNTHER</creator><general>Lippincott-Raven Publishers</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199401</creationdate><title>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</title><author>RETTENBACHER, LUKAS ; GALVAN, GÜNTHER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2808-7ac7d7bcd8391419500f278c722d14dd53e86debceab701f8e562ff1a911153b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>Child, Preschool</topic><topic>Citrates</topic><topic>Citric Acid</topic><topic>Diagnosis, Differential</topic><topic>Gallium Radioisotopes</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Indium Radioisotopes</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Lymphoma, Non-Hodgkin - diagnostic imaging</topic><topic>Medical sciences</topic><topic>Octreotide</topic><topic>Radionuclide Imaging</topic><topic>Receptors, Somatostatin</topic><topic>Thymus Hyperplasia - diagnostic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RETTENBACHER, LUKAS</creatorcontrib><creatorcontrib>GALVAN, GÜNTHER</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RETTENBACHER, LUKAS</au><au>GALVAN, GÜNTHER</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>1994-01</date><risdate>1994</risdate><volume>19</volume><issue>1</issue><spage>64</spage><epage>65</epage><pages>64-65</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><coden>CNMEDK</coden><abstract>In patients with treated malignant lymphoma, Ga-67 uptake in the mediastinum is seen only in viable lymphoma, but not in fibrotic or necrotic tissue. However, in children increased Ga-67 uptake in the mediastinum may be observed because of thymic hyperplasia. Somatostatin- receptor-scintigraphy is also a sensitive method in detection of malignant lymphoma. The authors present findings that suggest somatostatin receptor scintigraphy may clarify false-positive Ga-67 imaging.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>Lippincott-Raven Publishers</pub><pmid>8137590</pmid><doi>10.1097/00003072-199401000-00018</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-9762 |
ispartof | Clinical nuclear medicine, 1994-01, Vol.19 (1), p.64-65 |
issn | 0363-9762 1536-0229 |
language | eng |
recordid | cdi_proquest_miscellaneous_76406463 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Biological and medical sciences Child, Preschool Citrates Citric Acid Diagnosis, Differential Gallium Radioisotopes Hematologic and hematopoietic diseases Humans Indium Radioisotopes Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoma, Non-Hodgkin - diagnostic imaging Medical sciences Octreotide Radionuclide Imaging Receptors, Somatostatin Thymus Hyperplasia - diagnostic imaging |
title | Differentiation Between Residual Cancer and Thymic Hyperplasia in Malignant Non-Hodgkinʼs Lymphoma With Somatostatin Receptor Scintigraphy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A58%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20Between%20Residual%20Cancer%20and%20Thymic%20Hyperplasia%20in%20Malignant%20Non-Hodgkin%CA%BCs%20Lymphoma%20With%20Somatostatin%20Receptor%20Scintigraphy&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=RETTENBACHER,%20LUKAS&rft.date=1994-01&rft.volume=19&rft.issue=1&rft.spage=64&rft.epage=65&rft.pages=64-65&rft.issn=0363-9762&rft.eissn=1536-0229&rft.coden=CNMEDK&rft_id=info:doi/10.1097/00003072-199401000-00018&rft_dat=%3Cproquest_pubme%3E76406463%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76406463&rft_id=info:pmid/8137590&rfr_iscdi=true |